Literature DB >> 15304284

Repair of rabbit segmental defects with the thrombin peptide, TP508.

Michael R Sheller1, Roger S Crowther, John H Kinney, Jinping Yang, Sherry Di Jorio, Tom Breunig, Darrell H Carney, James T Ryaby.   

Abstract

The synthetic peptide, TP508 (Chrysalin), was delivered to rabbit segmental bone defects in biodegradable controlled-release PLGA microspheres to determine its potential efficacy for enhancing healing of non-critically and critically sized segmental defects. Non-critically sized radial defects were created in the forelimbs of New Zealand White rabbits, which were randomized into three treatment groups receiving 10, 50 and 100 microg doses of TP508 in the right radius and control microspheres (without TP508) in the left radius. Torsional testing of the radii at six weeks showed a significant increase in ultimate torque, failure torque, ultimate energy, failure energy, and stiffness when treated with TP508 compared to controls (p<0.01 for all measures). Thus, TP508 appeared to enhance or accelerate bone growth in these defects. In a second set of experiments, critically sized ulnar defects were created in the forelimbs of New Zealand White rabbits, which were randomized into two groups with each rabbit receiving microspheres with 100 or 200 microg of TP508 into the right ulnar defect and control microspheres (without TP508) alone into the left ulnar defect. Bone healing was evaluated with plain radiographs, synchrotron-based microtomography, and mechanical testing. Radiographs of the rabbit limbs scored by three blinded, independent reviewers demonstrated a significantly higher degree of healing when treated with TP508 than their untreated control limbs (p<0.05). Three-dimensional synchrotron tomography of a limited number of samples showed that the new bone in TP508-treated samples had a less porous surface appearance and open marrow spaces, suggesting progression of bone remodeling. Torsional testing of the ulnae at nine weeks showed a significant increase in maximum torque and failure energy when treated with TP508 compared to controls (p<0.01 for both measures). These results suggest that TP508 in a controlled release delivery vehicle has the potential to enhance healing of segmental defects in both critically and non-critically sized defects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304284     DOI: 10.1016/j.orthres.2004.03.009

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  19 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  Bone regeneration during distraction osteogenesis.

Authors:  Lisa R Amir; Vincent Everts; Antonius L J J Bronckers
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

Review 3.  Harnessing and modulating inflammation in strategies for bone regeneration.

Authors:  Paschalia M Mountziaris; Patrick P Spicer; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

Review 4.  Bone tissue engineering: recent advances and challenges.

Authors:  Ami R Amini; Cato T Laurencin; Syam P Nukavarapu
Journal:  Crit Rev Biomed Eng       Date:  2012

5.  Angiogenesis in bone regeneration.

Authors:  Kurt D Hankenson; Michael Dishowitz; Chancellor Gray; Mara Schenker
Journal:  Injury       Date:  2011-04-12       Impact factor: 2.586

6.  Custom-made composite scaffolds for segmental defect repair in long bones.

Authors:  Johannes C Reichert; Martin E Wullschleger; Amaia Cipitria; Jasmin Lienau; Tan K Cheng; Michael A Schütz; Georg N Duda; Ulrich Nöth; Jochen Eulert; Dietmar W Hutmacher
Journal:  Int Orthop       Date:  2010-12-07       Impact factor: 3.075

7.  Effect of dimerized thrombin fragment TP508 on acute myocardial ischemia reperfusion injury in hypercholesterolemic swine.

Authors:  Shizu Oyamada; Robert Osipov; Cesario Bianchi; Michael P Robich; Jun Feng; Yuhong Liu; Thomas A Burgess; Timothy M Bell; Michael R Sheller; Frank W Sellke
Journal:  J Pharmacol Exp Ther       Date:  2010-05-11       Impact factor: 4.030

8.  Nuclear Countermeasure Activity of TP508 Linked to Restoration of Endothelial Function and Acceleration of DNA Repair.

Authors:  Barbara Olszewska-Pazdrak; Scott D McVicar; Kempaiah Rayavara; Stephanie M Moya; Carla Kantara; Chris Gammarano; Paulina Olszewska; Gerald M Fuller; Laurie E Sower; Darrell H Carney
Journal:  Radiat Res       Date:  2016-07-07       Impact factor: 2.841

9.  Systemic administration of thrombin peptide TP508 enhances VEGF-stimulated angiogenesis and attenuates effects of chronic hypoxia.

Authors:  Barbara Olszewska-Pazdrak; Darrell H Carney
Journal:  J Vasc Res       Date:  2013-04-16       Impact factor: 1.934

Review 10.  Modulation of the inflammatory response for enhanced bone tissue regeneration.

Authors:  Paschalia M Mountziaris; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2008-06       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.